Early detection and accurate diagnosis play a crucial role in the successful management and improved outcomes of PCa, and the diagnostic process typically includes various procedures, such as prostate biopsy, digital rectal examination, prostate-specific antigen (PSA) testing, magnetic resonance imaging, or routine screening. This evidence concerns the gene KLK3 and posterior cortical atrophy.